I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 8 studies | 48% ± 23% | |
| retinal cone cell | 4 studies | 35% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 8 studies | 48% ± 23% | |
| retinal cone cell | 4 studies | 35% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 39% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 81% | 14231.68 | 2139 / 2642 | 96% | 35.49 | 674 / 705 |
| adrenal gland | 55% | 1196.40 | 141 / 258 | 80% | 48.91 | 185 / 230 |
| intestine | 71% | 5457.47 | 690 / 966 | 16% | 1.06 | 85 / 527 |
| pancreas | 0% | 1.60 | 1 / 328 | 81% | 7.57 | 144 / 178 |
| lung | 22% | 255.27 | 130 / 578 | 50% | 11.32 | 582 / 1155 |
| prostate | 9% | 87.82 | 22 / 245 | 54% | 1.40 | 269 / 502 |
| esophagus | 31% | 441.92 | 450 / 1445 | 21% | 0.86 | 38 / 183 |
| stomach | 32% | 974.10 | 116 / 359 | 19% | 1.37 | 54 / 286 |
| skin | 15% | 128.30 | 273 / 1809 | 27% | 2.71 | 128 / 472 |
| eye | 0% | 0 | 0 / 0 | 31% | 2.01 | 25 / 80 |
| bladder | 10% | 49.24 | 2 / 21 | 17% | 0.99 | 86 / 504 |
| spleen | 24% | 224.90 | 59 / 241 | 0% | 0 | 0 / 0 |
| uterus | 4% | 35.24 | 6 / 170 | 17% | 1.99 | 79 / 459 |
| muscle | 20% | 319.54 | 158 / 803 | 0% | 0 | 0 / 0 |
| ovary | 8% | 146.87 | 14 / 180 | 11% | 0.23 | 48 / 430 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 1.40 | 5 / 29 |
| thymus | 1% | 4.19 | 4 / 653 | 16% | 20.97 | 97 / 605 |
| breast | 1% | 6.62 | 3 / 459 | 14% | 3.03 | 161 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 9.86 | 6 / 45 |
| liver | 0% | 0 | 0 / 226 | 9% | 0.51 | 36 / 406 |
| kidney | 1% | 8.04 | 1 / 89 | 4% | 0.32 | 36 / 901 |
| blood vessel | 2% | 18.85 | 30 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 0% | 6.82 | 6 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 3.47 | 4 / 929 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.73 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0043653 | Biological process | mitochondrial fragmentation involved in apoptotic process |
| GO_0071333 | Biological process | cellular response to glucose stimulus |
| GO_0006839 | Biological process | mitochondrial transport |
| GO_0035865 | Biological process | cellular response to potassium ion |
| GO_0060385 | Biological process | axonogenesis involved in innervation |
| GO_0007268 | Biological process | chemical synaptic transmission |
| GO_0097107 | Biological process | postsynaptic density assembly |
| GO_0099645 | Biological process | neurotransmitter receptor localization to postsynaptic specialization membrane |
| GO_0007417 | Biological process | central nervous system development |
| GO_0043083 | Cellular component | synaptic cleft |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0030133 | Cellular component | transport vesicle |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | NPTX1 |
| Protein name | Pentraxin family member Neuronal pentraxin-1 (NP1) (Neuronal pentraxin I) (NP-I) |
| Synonyms | |
| Description | FUNCTION: May be involved in mediating uptake of synaptic material during synapse remodeling or in mediating the synaptic clustering of AMPA glutamate receptors at a subset of excitatory synapses. . |
| Accessions | Q15818 ENST00000571100.2 ENST00000306773.5 A0A8Q3WL24 |
